On Tuesday, Shares of PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI), gained 2.48% to $9.50.
PlasmaTech Biopharmaceuticals, declared that it had filed its first quarter 2015 report on Form 10-Q with the U.S. Securities and Exchange Commission and will provide a business update for investors on a conference call to be held Wednesday, May 27th at 10:00 AM (EDT).
Steven H. Rouhandeh, Executive Chairman, together with Tim Miller, Ph.D., President and CEO of Abeona Therapeutics LLC and prospective CEO of the combined companies upon closing of the acquisition, together with other executives, will conduct the call. Interested parties are invited to take part in the call by dialing: Toll Free Number: 877-269-7756 or International Toll Free Number: 201-689-8457.
PlasmaTech Biopharmaceuticals, Inc. operates as a biopharmaceutical company and develops protein biologic therapies and oncology supportive care products. The company’s marketed product comprises MuGard the administration of oral mucositis; and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region.
Shares of CDW Corporation (NASDAQ:CDW), declined -2.05% to $36.77, during its last trading session.
CDW Corporation, declared the pricing of a public offering of 10,000,000 shares of its common stock held by selling stockholders at a price to the public of $36.80 per share. The underwriters have a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the selling stockholders at the public offering price, less underwriting discounts. CDW Corporation will not receive any of the proceeds from the sale of the shares of common stock. The offering is predictable to close on May 22, 2015.
Barclays Capital Inc. and Goldman, Sachs & Co. are acting as underwriters in this offering.
CDW Corporation distributes information technology (IT) solutions in the United States and Canada. It operates in two segments, Corporate and Public. The company offers discrete hardware and software products to integrated IT solutions, counting mobility, security, data center optimization, cloud computing, virtualization, and collaboration.
At the end of Tuesday’s trade, Shares of Spectra Energy Corp. (NYSE:SE), lost -1.24% to $35.88.
Spectra Energy Partners’ (SEP) Bill Yardley will speak at the National Association of Publicly Traded Partnerships (NAPTP) 2015 MLP Investor Conference on Thursday, May 21, 2015. Yardley is president of U.S. Transmission and Storage for Spectra Energy Corp (SE), the general partner of Spectra Energy Partners.
The presentation is planned to start at 3:30 p.m. ET and will be accessible via webcast.
Spectra Energy Corp, through its auxiliaries, owns and operates a portfolio of natural gas-related energy assets in North America. The company’s Spectra Energy Partners segment engages in the transmission, storage, and gathering of natural gas, in addition to transportation and storage of crude oil and natural gas liquids (NGLs) for customers in various regions of the midwestern, northeastern, and southeastern United States and Canada.
Finally, CONSOL Energy Inc. (NYSE:CNX), ended its last trade with -1.72% loss, and closed at $30.83.
CONSOL Energy, declared that members of its executive administration team will take part in the 2015 National Association of Publicly Traded Partnerships (“NAPTP”) Investor Conference on May 21-22.
John T. Lewis, Chairman of the Board and Chief Executive Officer of CONE Midstream GP LLC (the “General Partner”) will give a presentation of the company’s operations and recent activities on Friday, May 22, at 10:45 a.m. Eastern Time.
CONSOL Energy Inc., together with its auxiliaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
